Geron Corp. Stock Price - GERN

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ and Amex.
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 2.38 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Geron Corp. GERN NASDAQ Common Stock US3741631036
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 2.38 2.54 2.35 2.37 2.38 20:00:00
Bid Price Ask Price Spread Spread % News
2.21 2.55 0.34 13.33% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,385 2,132,212 $ 2.4400 $ 5.2M 2.09M 1.74 - 3.15
Last Trade Time Type Quantity Stock Price Currency
16:50:21 17 $2.36 USD
Industry Sector

Geron Corp. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 378.97M 159.23M $ -29.54M -0.19 0.00 134.65M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.00 0.00% 18.21k 35.20%

more financials information »

Geron Corp. News

Latest GERN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GERN Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week2.42.542.0252.26142M6M3M-0.02-0.83%
1 Month1.92.751.842.3773949k14M3M0.4825.26%
3 Months1.962.751.782.1674563k14M2M0.4221.43%
6 Months2.032.751.742.1364402k14M2M0.3517.24%
1 Year2.293.151.742.3182230k15M2M0.093.93%
3 Years3.225.31.743.063857325M2M-0.84-26.09%
5 Years1.457.790.983.207157348M3M0.9364.14%

Geron Corp. Description

Geron Corporation develops therapeutic products for cancer that inhibit telomerase. Its product candidate include Imetelstat, a telomerase inhibitor, which is in Phase II clinical trials.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.